Discontinued — last reported Q3 '22
Caterpillar Acquisitions increased by 320.0% to $21.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 950.0%, from $2.00M to $21.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -44.3% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.00M | $51.00M | $41.00M | $8.00M | $28.00M | $8.00M | $44.00M | $5.00M | $15.00M | $47.00M | $8.00M | $0.00 | $32.00M | $0.00 | $2.00M | $2.00M | $19.00M | $5.00M | $21.00M |
| QoQ Change | — | +325.0% | -19.6% | -80.5% | +250.0% | -71.4% | +450.0% | -88.6% | +200.0% | +213.3% | -83.0% | -100.0% | — | -100.0% | — | +0.0% | +850.0% | -73.7% | +320.0% |
| YoY Change | — | — | — | — | +133.3% | -84.3% | +7.3% | -37.5% | -46.4% | +487.5% | -81.8% | -100.0% | +113.3% | -100.0% | -75.0% | — | -40.6% | — | +950.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.